Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people

Clinical and Experimental Immunology

Volumn 132, Issue 1, 2003, Pages 24-31

  Bruunsgaard, Helle ^a,b   Ladelund, S ^c   Pedersen, A N ^c   Schroll, M ^c   Jorgensen T ^c   Pedersen, B K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c NONE

Author keywords

Ageing; IL 6; Inflammation; Mortality; TNF

Indexed keywords

ANTIINFLAMMATORY AGENT; CHOLESTEROL; CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGE; AGED; AGING; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DRUG USE; EXERCISE; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; MALE; MORTALITY; NORMAL HUMAN; PATHOGENESIS; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE; SMOKING; SURVIVAL;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COMORBIDITY; DEATH; FEMALE; HUMANS; INTERLEUKIN-6; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0347367048     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02137.x     Document Type: Article

References (45)

1. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol 2001; 8:131-6.
2. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol Med Sci 1999; 54A:M357-64.
3. Franceschi C, Bonafé M, Valensin S et al. Inflamm-aging. An evolutionary perspective of immunosenescence. Ann NY Acad Sci 2000; 908:244-54.
4. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101:1767-72.
5. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101:2149-53.
6. Volpato S, Guralnik JM, Ferrucci L et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 2001; 103:947-53.
7. Bruunsgaard H, Skinhøj P, Pedersen AN, Schroll M, Pedersen BK. Ageing, TNF-alpha and atherosclerosis. Clin Exp Immunol 2000; 121:255-60.
8. Skoog T, Dichtl W, Boquist S et al. Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J 2002; 23:376-83.
9. Hamerman D. Toward an understanding of frailty. Ann Intern Med 1999; 130:945-50.
10. Ferrucci L, Harris TB, Guralnik JM et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999; 47:639-46.
11. Paolisso G, Rizzo MR, Mazziotti G et al. Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol Endocrin Metab 1998; 38:E294-E299.
12. Harris TB, Ferrucci L, Tracy RP et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106:506-12.
13. Jaattela M. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. Lab Invest 1991; 64:724-42.
14. Grunfeld C, Palladino M. Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities. Adv Intern Med 1990; 35:45-71.
15. Woods A, Brull DJ, Humphries SE, Montgomery HE. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 2000; 21:1574-83.
16. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148:209-14.
17. Liu J, Marino MW, Wong G et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 1998; 4:78-83.
18. Richards C, Gauldie J. Role of cytokines in the acute-phase response. In: Aggarwal BB, Purl RK, eds. Human cytokines: their roles in disease and therapy. Cambridge, MA: Blackwell Science, 1995.
19. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997; 18:428-32.
20. Xing Z, Gauldie J, Cox G et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101:311-20.
21. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994; 83:113-8.
22. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP. New insights into the biology of the acute phase response. J Clin Immunol 1999; 19:203-14.
23. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 1993; 41:176-81.
24. Schroll M. A ten-year prospective study, 1964-74, of cardiovascular risk factors in men and women from the Glostrup population born in 1914. Dan Med Bull 1982; 29:213-52.
25. Schroll M, Jorgensen T, Ingerslev J. The Glostrup Population Studies, 1964-92. Dan Med Bull 1992; 39:204-7.
26. Ihaka R, Gentleman R. A language for data analysis and graphics. J Computational Graph Statistics 1996; 5:299-314.
27. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-26.
28. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997; 96:3042-7.
29. Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev 1999; 10:27-39.
30. Hotamisligil GS. The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999; 245:621-5.
31. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327-34.
32. Schmidt MI, Duncan BB, Sharrett AR et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999; 353:1649-52.
33. Metzger S, Hassin T, Barash V, Pappo O, Chajek-Shaul T. Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor. Am. J Physiol Endocrinol Metab 2001; 281:E957-E965.
34. Wallenius V, Wallenius K, Ahren B et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002; 8:75-9.
35. Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol 2001; 115:3-12.
36. Reid MB, Li YP. Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir Res 2001; 2:269-72.
37. Pacifici R. Aging and cytokine production. Calcif Tissue Int 1999; 65:345-51.
38. Cohen HJ, Pieper CF, Harris T, Rao KK, Currie MS. The association of plasma IL-6 levels with functional disability in community dwelling elderly. J Gerontol Med Scien 1997; 52:M201-8.
39. Olivieri F, Bonafe M, Cavallone L et al. The -174 C/G locus affects in vitro/in vivo IL-6 production during aging. Exp Gerontol 2002; 37:309-14.
40. Bonafe M, Olivieri F, Cavallone L et al. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 2001; 31:2357-61.
41. Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK. Impaired production of proinflammatory cytokines in response to LPS stimulation in elderly humans. Clin Exp Immunol 1999; 118:235-41.
42. Reuben DB, Cheh AI, Harris TB et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002; 50:638-44.
43. Weijenberg MP, Feskens EJ, Souverijn JH, Kromhout D. Serum albumin, coronary heart disease risk, and mortality in an elderly cohort. Epidemiology 1997; 8:87-92.
44. Rosenthal AJ, McMurtry CT, Sanders KM, Jacobs M, Thompson D, Adler RA. The soluble interleukin-2 receptor predicts mortality in older hospitalized men. J Am Geriatr Soc 1997; 45:1362-4.
45. Ettinger WHJ, Sun WH, Binkley N, Kouba E, Ershler W. Interleukin-6 causes hypocholesterolemia in middle-aged and old rhesus monkeys. J Gerontol A Biol Sci Med Sci 1995; 50:M137-40.